Litcius/Paper detail

Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01

Jinghua Piao, Susan E. Zabierowski, Brittany N. Dubose, Ellen J. Hill, Monalisa Navare, Nidia Claros, Siera Rosen, Kiran Ramnarine, Callie Horn, Craig Fredrickson, Karen Wong, Brent Safford, Sonja Kriks, Abderrahman El Maarouf, Urs Rutishauser, Claire Henchcliffe, Yongzeng Wang, Isabelle Rivière, Shannon E. Mann, Vladimir P. Bermudez, Stefan Irion, Lorenz Studer, Mark Tomishima, Viviane Tabar

2021Cell stem cell253 citationsDOIOpen Access PDF

Topics & Concepts

BiologyEmbryonic stem cellDopamineMidbrainProgenitor cellStem cellProgenitorCell biologyNeuroscienceCancer researchGeneticsCentral nervous systemGenePluripotent Stem Cells ResearchBiomedical Ethics and RegulationNuclear Receptors and Signaling
Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01 | Litcius